Related Experiment Video
Updated: Dec 8, 2025
05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
509
Pregnancy and COVID-19: pharmacologic considerations
Summary
This review details pharmacologic interventions for pregnant and lactating patients with COVID-19. Key recommendations include antenatal corticosteroids, aspirin for pregnancy complications, and cautious use of other agents like dexamethasone for severe cases.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Pregnant and lactating individuals with COVID-19 present unique challenges for pharmacologic management.
- Evidence-based guidelines are crucial for optimizing maternal and fetal outcomes.
Purpose of the Study:
- To review and summarize current evidence on pharmacologic interventions for pregnant and lactating patients with COVID-19.
- To provide guidance on the use of routine and investigational medications during pregnancy and lactation.
Main Methods:
- Comprehensive literature review of pharmacologic treatments for COVID-19 in pregnant and lactating populations.
- Analysis of data regarding efficacy, safety, and specific indications for various medications.
Main Results:
- Antenatal corticosteroids for fetal lung maturation are recommended between 24-34 weeks gestation.
- Low-dose aspirin is safe for preventing placenta-mediated complications; thromboprophylaxis requires individualized assessment.
- Dexamethasone is the only proven treatment for mechanically ventilated or oxygen-dependent pregnant patients with COVID-19.
Conclusions:
- Specific pharmacologic interventions are recommended for pregnant and lactating patients with COVID-19, with careful consideration of gestational age and disease severity.
- Further research is needed for investigational treatments like monoclonal antibodies and immunomodulators in this population.
More Related Videos
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
3.4K
05:17Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
Published on: April 5, 2024
1.1K
Related Concept Videos
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
742
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
742
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.0K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.0K
01:21Factors Affecting Drug Response: Overview
2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
105
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
105
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
01:25Pharmacokinetics: Drug–Drug Interactions
179
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
179